A preliminary study to evaluate efficacy and safety of Lugol’s solution following radioiodine for remnant ablation in differentiated thyroid cancer
It was registered at Chinese Clinical Trial Registry with identifier ChiCTR1900027705 at November 24<sup>th</sup>, 2019.
Authors
- Yunyun Zhu (ORCID: https://orcid.org/0000-0002-0985-2993)
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Quanyong Luo
- Chentian Shen
Institutions
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.3389/fonc.2026.1783763
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Jiao Tong University